(19)
(11) EP 3 011 936 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
24.07.2019 Bulletin 2019/30

(45) Mention of the grant of the patent:
13.03.2019 Bulletin 2019/11

(21) Application number: 15196598.5

(22) Date of filing: 06.01.2012
(51) International Patent Classification (IPC): 
A61L 27/34(2006.01)
A61F 2/04(2013.01)
B29L 23/00(2006.01)
A61F 2/82(2013.01)
A61F 2/06(2013.01)

(54)

TISSUE-ENGINEERED CONSTRUCTS

GEWEBEGEZÜCHTETE KONSTRUKTE

CONSTRUCTIONS OBTENUES PAR GÉNIE TISSULAIRE


(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 06.01.2011 US 201161430381 P

(43) Date of publication of application:
27.04.2016 Bulletin 2016/17

(62) Application number of the earlier application in accordance with Art. 76 EPC:
12731951.5 / 2661243

(73) Proprietor: Humacyte, Inc.
Durham, NC 27713 (US)

(72) Inventors:
  • DAHL, Shannon L.M.
    Palo Alto, CA 94304 (US)
  • NIKLASON, Laura E.
    Greenwich, CT 06519 (US)
  • BLUM, Juliana
    Wake Forest, NC 27587 (US)
  • STRADER, Justin T.
    Durham, NC 27713 (US)
  • TENTE, William E.
    Seekonk, MA 02771 (US)
  • PRICHARD, Heather L.
    Wake Forest, NC 27587 (US)
  • LUNDQUIST, Joseph J.
    Durham, NC 27713 (US)

(74) Representative: Cooley (UK) LLP 
Dashwood 69 Old Broad Street
London EC2M 1QS
London EC2M 1QS (GB)


(56) References cited: : 
WO-A1-99/32536
US-A1- 2009 163 990
US-A- 3 588 920
   
  • SHANNON L M DAHL ET AL: "Mechanical Properties and Compositions of Tissue Engineered and Native Arteries", ANNALS OF BIOMEDICAL ENGINEERING, KLUWER ACADEMIC PUBLISHERS-PLENUM PUBLISHERS, NE, vol. 35, no. 3, 6 January 2007 (2007-01-06), pages 348-355, XP019477052, ISSN: 1573-9686, DOI: 10.1007/S10439-006-9226-1
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).